These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15300803

  • 1. Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.
    Meziane el K, Bhattacharyya T, Armstrong AC, Qian C, Hawkins RE, Stern PL, Dermime S.
    Int J Cancer; 2004 Oct 10; 111(6):910-20. PubMed ID: 15300803
    [Abstract] [Full Text] [Related]

  • 2. CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines.
    Rieger R, Kipps TJ.
    Cancer Res; 2003 Jul 15; 63(14):4128-35. PubMed ID: 12874017
    [Abstract] [Full Text] [Related]

  • 3. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
    Briones J, Timmerman J, Levy R.
    Cancer Res; 2002 Jun 01; 62(11):3195-9. PubMed ID: 12036933
    [Abstract] [Full Text] [Related]

  • 4. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC, Dermime S, Allinson CG, Bhattacharyya T, Mulryan K, Gonzalez KR, Stern PL, Hawkins RE.
    J Immunol; 2002 Apr 15; 168(8):3983-91. PubMed ID: 11937555
    [Abstract] [Full Text] [Related]

  • 5. Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
    Briones J, Timmerman JM, Panicalli DL, Levy R.
    J Natl Cancer Inst; 2003 Apr 02; 95(7):548-55. PubMed ID: 12671023
    [Abstract] [Full Text] [Related]

  • 6. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S, Yotnda P, Rousseau RF, Mei Z, Smith S, Rill D, Younes A, Brenner MK.
    Cancer Gene Ther; 2001 May 02; 8(5):378-87. PubMed ID: 11477458
    [Abstract] [Full Text] [Related]

  • 7. Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.
    Alvarez E, Moga E, Barquinero J, Sierra J, Briones J.
    Gene Ther; 2010 Apr 02; 17(4):469-77. PubMed ID: 20010627
    [Abstract] [Full Text] [Related]

  • 8. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA, DeBenedette MA, Watts TH, Berinstein NL.
    J Immunol; 1999 Apr 15; 162(8):5003-10. PubMed ID: 10202049
    [Abstract] [Full Text] [Related]

  • 9. B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma.
    Pizzoferrato E.
    Int J Cancer; 2004 May 20; 110(1):61-9. PubMed ID: 15054869
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand.
    Liu A, Guardino A, Chinsangaram L, Goldstein MJ, Panicali D, Levy R.
    Cancer Res; 2007 Jul 15; 67(14):7037-44. PubMed ID: 17638917
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA, Lukacs-Kornek V, Timmerman A, Shabani S, Kornek M, Vogt A, Yildiz Y, Sievers E, Schmidt-Wolf IG, Caselmann WH, Sauerbruch T, Schmitz V.
    Hepatology; 2008 Jul 15; 48(1):157-68. PubMed ID: 18537185
    [Abstract] [Full Text] [Related]

  • 13. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD.
    Cancer Res; 2002 Nov 15; 62(22):6545-51. PubMed ID: 12438249
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
    Guinn BA, Bertram EM, DeBenedette MA, Berinstein NL, Watts TH.
    Cell Immunol; 2001 May 25; 210(1):56-65. PubMed ID: 11485353
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H, Thielemanns K, Tesch H, Engert A, Wolf HJ, van Camp B, Urbain J, Diehl V.
    Cytokines Mol Ther; 1996 Dec 25; 2(4):231-8. PubMed ID: 9384709
    [Abstract] [Full Text] [Related]

  • 18. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G, Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK.
    Hum Gene Ther; 2001 Apr 10; 12(6):659-70. PubMed ID: 11426465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.